Charting a new course through the chaos of KS (Kaposi's sarcoma)

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma.The Journal of clinical investigation · 1997
   Article
2. HHV8 and Kaposi's sarcoma: a time cohort study.Molecular pathology : MP · 1997
   Article
3. Kaposi's sarcoma associated herpes virus (KSHV/HHV 8): epidemiology, molecular biology and tissue distribution.Molecular pathology : MP · 1997
   Review
4. Kaposi's sarcoma tumor cells preferentially express Bcl-xL.The American journal of pathology · 1996
   Article

Corrections and comments

• Comment on
  CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.1996

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as